ADAG News

The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider Cloopen Group (RAAS), which bagged the biggest pop of 2021 to date. Bumble (BMBL) priced further...read more

Adagene, a Phase 1 biotech developing antibody cancer immunotherapies in China, raised $140 million by offering 7.4 million ADSs at $19, the high end of the range of $17 to $19. Adagene's proprietary AI-Powered DPL platform explores the dynamic conformational diversity of protein sequences, and the flexible binding sites of antibody sequences in particular, as a new paradigm...read more

Updated Monday, 2/8. The IPO market is buzzing with 15 IPOs slated to raise $4.0 billion in the week ahead, led by dating app Bumble’s billion-dollar offering. Bumble (BMBL) plans to raise $1.7 billion at a $7.5 billion market cap. The company operates the Bumble and Badoo apps, the world’s second and fourth highest grossing dating...read more

Adagene, a Phase 1 biotech developing antibody cancer immunotherapies in China, announced terms for its US IPO on Wednesday. The Suzhou, China-based company plans to raise $132 million by offering 7.4 million ADSs at a price range of $17 to $19. At the midpoint of the proposed range, Adagene would command a fully diluted market value of $831 million. Adagene is a platform...read more